Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

141 questions in 31 reviews · Emergency and Critical Care

current versions
No studies 141 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
FINLAY‐FR‐2 – Instituto Finlay de Vacunas vs placebo
Confirmed SARS‐CoV‐2 infection
Efficacy and safety of COVID‐19 vaccines (2022) · Cochrane
no estimate extractedNRNo studies
FINLAY‐FR‐2 – Instituto Finlay de Vacunas vs placebo
Severe or critical COVID‐19
Efficacy and safety of COVID‐19 vaccines (2022) · Cochrane
no estimate extractedNRNo studies
HFNC vs NIPPV or NIV
Nasal mucosa or skin trauma · adults in the ICU, requiring respiratory support
High‐flow nasal cannulae for respiratory support in adult intensive care patients (2021) · Cochrane
no estimate extractedNRNo studies
Surfactants vs control
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
N‐acetylcysteine vs control
Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
N‐acetylcysteine vs control
Duration of mechanical ventilation · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
N‐acetylcysteine vs control
Ventilator‐free days up to day 28 · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
N‐acetylcysteine vs control
Adverse events Defined as leading to discontinuation of study medication · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
N‐acetylcysteine vs control
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Statins vs control
Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Statins vs control
Adverse events Defined as leading to discontinuation of study medication · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Statins vs control
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Beta‐agonist vs control
Late all‐cause mortality (> 3 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Beta‐agonist vs control
Duration of mechanical ventilation · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Beta‐agonist vs control
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Corticosteroids vs control
Adverse events Defined as leading to discontinuation of study medication; or for studies with standard care control, defined by study authors as "serious adverse events" · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Corticosteroids vs control
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
Pharmacological agents for adults with acute respiratory distress syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Buffered solutions vs 0.9% saline
Electrolyte disturbances · critically ill adults and children
Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children (2019) · Cochrane
no estimate extractedNRNo studies
Early enteral nutrition with supplemental parenteral nutrition (SPN) vs delayed enteral nutrition with SPN
Hospital length of stay (measured in days) · critically ill adults
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without… (2019) · Cochrane
no estimate extractedNRNo studies
Early enteral nutrition with supplemental parenteral nutrition (SPN) vs delayed enteral nutrition with SPN
Pneumonia (as defined by the authors) ( · critically ill adults
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without… (2019) · Cochrane
no estimate extractedNRNo studies
Early enteral nutrition with supplemental parenteral nutrition (SPN) vs delayed enteral nutrition with SPN
Feed intolerance or gastrointestinal complications (as defined by the authors) · critically ill adults
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without… (2019) · Cochrane
no estimate extractedNRNo studies
Mobilization of community first responders (CFRs) in addition to routine emergency medical services (EMS) care vs routine EMS care
Neurological function at hospital discharge, measured by cerebral performance category (CPC) · adults and children more than 4 weeks old suffering from OHCA
Community first responders for out‐of‐hospital cardiac arrest in adults and children (2019) · Cochrane
no estimate extractedNRNo studies
Mobilization of community first responders (CFRs) in addition to routine emergency medical services (EMS) care vs routine EMS care
Neurological function at 30 days, measured by cerebral performance category (CPC) · adults and children more than 4 weeks old suffering from OHCA
Community first responders for out‐of‐hospital cardiac arrest in adults and children (2019) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Comparison: outcome · participants at risk of high altitude illness
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological… (2019) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Comparison: outcome · participants at risk of high altitude illness
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological… (2019) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Comparisons: outcome · participants at risk of high altitude illness
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological… (2019) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Outcomes and intervention · people suffering from high altitude illness
Interventions for treating acute high altitude illness (2018) · Cochrane
no estimate extractedNRNo studies
Intervention NR
All‐cause mortality · people suffering from high altitude illness
Interventions for treating acute high altitude illness (2018) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Complete relief of AMS symptoms · people suffering from high altitude illness
Interventions for treating acute high altitude illness (2018) · Cochrane
no estimate extractedNRNo studies
Intervention NR
All‐cause mortality · people suffering from high altitude illness
Interventions for treating acute high altitude illness (2018) · Cochrane
no estimate extractedNRNo studies
Haloperidol vs placebo
Cognitive impairment · critically ill patients 18 years or older demanding mechanical ventilation within the first 72 hours (Page 2013) or…
Interventions for preventing intensive care unit delirium in adults (2018) · Cochrane
no estimate extractedNRNo studies
Physical and cognitive therapy vs standard care
The event rate of ICU delirium measured by the CAM‐ICU · critically ill patients 18 years or older treated for respiratory failure or septic or both, cardiogenic or…
Interventions for preventing intensive care unit delirium in adults (2018) · Cochrane
no estimate extractedNRNo studies
BIS monitoring vs clinical assessment
Other important secondary outcomes like Any‐cause mortality, ventilator‐associated pneumonia, hospital LOS, amount of sedative agents used, long term functional outcomes and quality of life were not reported in any studies · Mechanically ventilated adults in the intensive care unit
BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs enteral and parenteral nutrition
Number of ventilator‐free days up to day 28 · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs enteral and parenteral nutrition
Adverse events: aspiration (as reported by study authors at end of study · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs enteral and parenteral nutrition
Adverse events: sepsis (as reported by study authors at end of study · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs enteral and parenteral nutrition
Adverse events: vomiting (as reported by study authors at end of study · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs parenteral nutrition
Number of ICU‐free days up to day 28 · critically ill adults admitted to the ICU for trauma, emergency, or surgical care; population excluded people with…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Enteral vs enteral and parenteral nutrition
Number of ICU‐free days up to day 28 · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes…
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for… (2018) · Cochrane
no estimate extractedNRNo studies
Automated monitoring systems vs standard care
Time to initiation of fluid resuscitation (Time to initiation starts at the time of admission) · participants of any age admitted to the intensive care or critical care unit for any reason (including, but not…
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients (2018) · Cochrane
no estimate extractedNRNo studies
Automated monitoring systems vs standard care
Quality of life measured at the latest available time point post‐discharge from ICU (preferred measure SF‐36 then EQ‐5D) · participants of any age admitted to the intensive care or critical care unit for any reason (including, but not…
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs no agent
Quantity and quality of sleep as measured through reports of participants or family members or by personnel assessments Data collected at end of study · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs another agent specifically administered to promote sleep
Adverse events (such as cardiovascular events, respiratory events or illness resulting from immune deficiency) · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs no agent
Anxiety or depression, or both, as measured using validated tools Data collected at end of study · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs no agent
Adverse events (such as cardiovascular events, respiratory events or illness resulting from immune deficiency) · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs propofol at a different rate or dose
Quantity and quality of sleep as measured by PSG, actigraphy, BIS or EEG Data collected at end of study · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs propofol at a different rate or dose
Anxiety or depression, or both, as measured using validated tools Data collected at end of study · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Propofol for the promotion of sleep in the intensive care unit vs propofol at a different rate or dose
Adverse events (such as cardiovascular events, respiratory events or illness resulting from immune deficiency) · critically ill adults in the intensive care unit
Propofol for the promotion of sleep in adults in the intensive care unit (2018) · Cochrane
no estimate extractedNRNo studies
Spironolactone vs placebo
Risk of adverse events ‐ not reported · participants at risk of high altitude illness
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs (2018) · Cochrane
no estimate extractedNRNo studies
Acetazolamide vs spironolactone
Risk of adverse events ‐ not reported · participants at risk of high altitude illness
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs (2018) · Cochrane
no estimate extractedNRNo studies